Hemicentral retinal artey occlusion in a breast cancer patient using anastrazole.
Küçük Resim Yok
Tarih
2009
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Karger
Erişim Hakkı
CC0 1.0 Universal
info:eu-repo/semantics/openAccess
info:eu-repo/semantics/openAccess
Özet
Background: Anastrozole, an aromatase inhibitor, is commonly used in the adjuvant treatment of breast cancer. Anastrozole treatment is associated with a risk of thromboembolic events and retinal vascular side effects. Herein, we present a case of hemicentral retinal artery occlusion diagnosed in a breast cancer patient using anastrozole. Case Report: A 53-year-old woman with a hypertensive and diabetic background was admitted to our hospital with breast cancer. Anastrozole treatment was started after surgery, adjuvant chemotherapy, and radiotherapy. Sudden painless loss of vision in the patient’s right eye occurred within 13 months of Anastrozole treatment. A fluorescein angiogram revealed hemicentral retinal artery occlusion. Conclusion: To the best knowledge of the authors, this is the first report of hemicentral retinal artery occlusion in an anastrozole user.
Açıklama
Anahtar Kelimeler
Anastrozole, Retinal artery, Thromboembolism, Breast cancer
Kaynak
Oncology Research and Treatment
WoS Q Değeri
Scopus Q Değeri
Q3
Cilt
32
Sayı
7
Künye
Karagöz, B., Ayata, A., Bilgi, O., Uzun, G., Unal, M., Kandemir, E. G., Ozgün, A. ve Türken, O. (2009). Hemicentral retinal artery occlusion in a breast cancer patient using anastrozole. Onkologie, Karger. 32(7), s. 421–423.
